Richney, I am also a long term holder and very surprised to read your comments on relevant historical tests. A quick review of company releases over a long period indicates to me that
- Airsonea, the previous version of Wheezo, never received FDA approval
-Airsonea was never "successfully tested" against spirometry, nor has Wheezo yet
- Airsonea achieved an 85% correlation with physicians using stethoscopes in 2016 , yet in 2020 RSH said Wheezo got only 46% in detecting wheeze before adjusting results.
IMO you are incorrect. If you have different company information please let all of us know how to find it. That would be helpful and encouraging.
Cheers
Stern
- Forums
- ASX - By Stock
- RSH
- Product tests & clinical results, facts please
Product tests & clinical results, facts please
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.002(6.67%) |
Mkt cap ! $29.67M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.8¢ | $13.44K | 464.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 196083 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 90348 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 196083 | 0.028 |
1 | 100000 | 0.027 |
1 | 4030 | 0.026 |
3 | 986428 | 0.025 |
2 | 165384 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 90348 | 1 |
0.031 | 497058 | 3 |
0.032 | 100000 | 1 |
0.033 | 100000 | 1 |
0.034 | 541012 | 2 |
Last trade - 15.58pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
2.8¢ |
  |
Change
-0.002 ( 3.45 %) |
|||
Open | High | Low | Volume | ||
2.9¢ | 2.9¢ | 2.8¢ | 10880 | ||
Last updated 14.54pm 28/03/2024 ? |
Featured News
RSH (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online